Investor Presentaiton
24
Innovative R&D - Incubation & Early Stage Investments
Incubation & Early Stage Investments: enrich the R&D pipeline to target cutting-edge technologies at an earlier stage
Incubation
Early-stage
Investment
Fosun Lead was founded in
2019, focusing on world-
leading biotechnologies and
information technologies.
Including gene therapy
platform GeCell, Al-assisting
precision medicine for
Oncology, personalized new
antigen immunotherapy and
others. Other projects
includes portable MRI,
handheld ultrasound device
and Protein Sequencer
Fusion is a platform under
Fosun Pharma US in
Boston and incubated
Archimmune
Therapeutics which has
two immuno-oncology
platforms: personalized
cancer vaccine (ACNP)
and Multi-specific immuno-
nano therapy (MINP)
Participated in overseas
healthcare professional
funds such as Pontifax
Venture Capital, Berkeley
Catalyst Fund I, LP
Partners Innovation Fund II,
LP for access to leading
technologies globally with
potential in-license and
other collaboration
opportunities
Fosun Health Capital has
completed financing as
Fosun's first VC fund for
innovative drugs. Project
invested so far include
Biomissile (bi-specific
antibody) and Tianjin
JuveStar (medical
aesthetic)View entire presentation